Related Experiment Video
Updated: Dec 6, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Targeted Degradation of Transcription Coactivator SRC-1 through the N-Degron Pathway
Yeongju Lee1, Jiwon Heo2, Hoibin Jeong3
1Department of Chemistry and Division of Advanced Materials Science, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, 37673, South Korea.
Abstract:
Aberrantly elevated steroid receptor coactivator-1 (SRC-1) expression and activity are strongly correlated with cancer progression and metastasis. Here we report, for the first time, the development of a proteolysis targeting chimera (PROTAC) that is composed of a selective SRC-1 binder linked to a specific ligand for UBR box, a unique class of E3 ligases recognizing N-degrons. We showed that the bifunctional molecule efficiently and selectively induced the degradation of SRC-1 in cells through the N-degron pathway. Importantly, given the ubiquitous expression of the UBR protein in most cells, PROTACs targeting the UBR box could degrade a protein of interest regardless of cell types. We also showed that the SRC-1 degrader significantly suppressed cancer cell invasion and migration in vitro and in vivo. Together, these results demonstrate that the SRC-1 degrader can be an invaluable chemical tool in the studies of SRC-1 functions. Moreover, our findings suggest PROTACs based on the N-degron pathway as a widely useful strategy to degrade disease-relevant proteins.
Insights
Scientists developed a novel proteolysis targeting chimera (PROTAC) to degrade steroid receptor coactivator-1 (SRC-1), a protein linked to cancer progression. This new chemical tool effectively reduced cancer cell invasion and migration, offering a promising strategy for cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Chemical Biology
Background:
- Aberrant expression of steroid receptor coactivator-1 (SRC-1) is linked to cancer progression and metastasis.
- Targeting SRC-1 is a potential therapeutic strategy for various cancers.
Purpose of the Study:
- To develop and characterize a novel proteolysis targeting chimera (PROTAC) for targeted SRC-1 degradation.
- To investigate the efficacy of the SRC-1 PROTAC in suppressing cancer cell invasion and migration.
Main Methods:
- Design and synthesis of a bifunctional PROTAC molecule linking an SRC-1 binder to a UBR box E3 ligase ligand.
- Assessment of SRC-1 degradation in cells via the N-degron pathway.
- In vitro and in vivo evaluation of the PROTAC's effect on cancer cell invasion and migration.
Main Results:
- The developed PROTAC efficiently and selectively induced SRC-1 degradation through the N-degron pathway.
- The SRC-1 degrader significantly suppressed cancer cell invasion and migration both in vitro and in vivo.
- The UBR box-based PROTAC strategy demonstrated broad applicability across cell types.
Conclusions:
- The novel SRC-1 PROTAC serves as a valuable chemical tool for studying SRC-1 functions in cancer.
- PROTACs utilizing the N-degron pathway represent a versatile strategy for degrading disease-associated proteins.
- Targeted SRC-1 degradation holds potential for inhibiting cancer progression and metastasis.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Regulation of Expression at Multiple Steps
Nuclear Export of mRNA

